Future Outlook
Company has already developed peptides like Linaclotide. The company is efficiently working on peptides like Liraglutide and Semaglutide and these are having huge commercial value going forward. These peptides being fairly complex in nature, the timelines for development for filing a DMF are longer.
Typical small molecules take anywhere from 3 to 9 months to file a DMF whereas the complex peptide-like Liraglutide or Semaglutide could take 2-2.5 years. But given that the opportunity is fairly large and the company is excited about these molecules and hopefully, the company is having few interesting partnerships on the generic peptide side.